Alzheimer’s trial to test drug on people without symptoms to see if it can be prevented

This exciting new trial is set to explore whether an experimental Alzheimer’s drug can prevent the onset of dementia in people who currently show no symptoms. Healthy middle-aged individuals at higher risk will be screened, and those with a specific biomarker will have the chance to participate. The PrevenTRON study aims to shift the focus from treating Alzheimer’s to preventing it altogether, which is a game changer! With the potential to help millions, this research could redefine how we approach this condition.